Crizotinib’s a medicine that targets ALK, ROS1, and MET. It’s mainly used to treat NSCLC, specifically in patients whose cancer has certain gene changes. How it works is by stopping these ALK, ROS1, and MET kinase proteins from doing their thing.
There are two capsule versions: one with 200 milligrams and the other with 250. Doctors usually suggest taking 250 milligrams, two times a day—whether you have something to eat or not, that’s up to you. Each bottle’s got 60 capsules inside.
This drug is really good at dealing with cancers that have certain genetic changes, which makes it super effective for advanced lung cancer patients.
